T 2717/17 (Buprenorphine/ HEXAL) of 28.11.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T271717.20191128
- Date of decision
- 28 November 2019
- Case number
- T 2717/17
- Petition for review of
- -
- Application number
- 11784951.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING BUPRENORPHINE
- Applicant name
- Hexal AG
- Opponent name
- LTS LOHMANN Therapie-Systeme AG
Generics [U.K.] Limited
Graf von Stosch, Andreas - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Late-filed document - admitted (no)
Late-filed attack on inventive step - admitted (no)
Grounds for opposition - insufficiency of disclosure (no)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- G 0003/97
Order
For these reasons it is decided that:
The appeals are dismissed